Sigachi Industries Ltd inaugurates state-of-the-art R&D Center in Hyderabad

Sigachi Industries Limited, a leading player in pharmaceutical industry has officially opened its new R&D Center in Hyderabad-an advanced facility designed to accelerate the development of critical APIs and enhance in-house analytical capabilities. The facility is poised to play a key role in advancing Sigachi's innovation roadmap and enhancing its responsiveness to global regulatory demands.

The Hyderabad R&D Center is designed to:

- Strengthen API development and regulatory alignment by integrating advanced systems for seamless synthesis, analytics, and global filings.

- Fuel pipeline growth through targeted investment of up to USD 1 million to support priority APIs and complex intermediates.

- Focus resources effectively by aligning the pharma product portfolio to strategic therapeutic segments.

- Empower a high-impact research team to lead development efforts for global markets.

Commenting on this development, Mr. Amit Raj Sinha, Managing Director and CEO of Sigachi Industries Limited stated "This R&D Center is a strategic asset that will significantly strengthen our development capabilities and enable us to respond swiftly to market needs, it reflects our focus on building operational depth and creating long-term value for our customers, partners, and stakeholders in an evolving global pharmaceutical environment."

Source : Equity Bulls

Keywords

SigachiIndustries RandDCenter Hyderabad Inauguration